Discontinuation report RUZURGI
Report ID | 156611 |
Drug Identification Number | 02503034 |
Brand name | RUZURGI |
Common or Proper name | Amifapridine |
Company Name | MEDUNIK CANADA |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 tablets |
ATC code | N07XX |
ATC description | |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2022-03-12 |
Actual discontinuation date | 2022-03-12 |
Remaining supply date | 2022-03-12 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | NOC retrival due to legal cause |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 950 MICHÈLE-BOHEC BLVD. BLAINVILLE, QUEBEC CANADA J7C 5E2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-03-14 | English | Compare |
v2 | 2022-03-14 | English | Compare |
v3 | 2022-03-14 | English | Compare |
v4 | 2022-03-14 | English | Compare |
v5 | 2022-03-14 | French | Compare |
v6 | 2023-01-27 | English | Compare |
v7 | 2023-01-27 | French | Compare |
Showing 1 to 7 of 7